High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias

被引：56

作者：

Facca, A ^{[1
]}

SanchezRamos, J ^{[1
]}

机构：

[1] MIAMI VET AFFAIRS MED CTR,GERIATR RES & EDUC CLIN CTR,MIAMI,FL

来源：

MOVEMENT DISORDERS | 1996年 / 11卷 / 03期

关键词：

D O I：

10.1002/mds.870110319

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：327 / 329

页数：3

共 7 条

[1] PARKINSONS-DISEASE - AN OPEN LABEL TRIAL OF PERGOLIDE IN PATIENTS FAILING BROMOCRIPTINE THERAPY [J].

FACTOR, SA ;

SANCHEZRAMOS, JR ;

WEINER, WJ .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1988, 51 (04) :529-533

[2]

LAITINEN LV, 1995, NEUROSURG CLIN N AM, V6, P105

[3] PERGOLIDE IN LATE-STAGE PARKINSON DISEASE [J].

LANG, AE ;

QUINN, N ;

BRINCAT, S ;

MARSDEN, CD ;

PARKES, JD .

ANNALS OF NEUROLOGY, 1982, 12 (03) :243-247

[4] PARKINSONS-DISEASE [J].

MARSDEN, CD .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (06) :672-681

[5] PERGOLIDE IN THE TREATMENT OF PARKINSONS-DISEASE [J].

MEAR, JY ;

BARROCHE, G ;

DESMET, Y ;

WEBER, M ;

LHERMITTE, F ;

AGID, Y .

NEUROLOGY, 1984, 34 (07) :983-986

[6]

Rinne UK, 1986, ADV NEUROL, V45, P519

[7] EARLY COMBINATION THERAPY (BROMOCRIPTINE AND LEVODOPA) DOES NOT PREVENT MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE [J].

WEINER, WJ ;

FACTOR, SA ;

SANCHEZRAMOS, JR ;

SINGER, C ;

SHELDON, C ;

CORNELIUS, L ;

INGENITO, A .

NEUROLOGY, 1993, 43 (01) :21-27

← 1 →